MEI Pharma Inc (MEIP)
3.29
+0.04
(+1.23%)
USD |
NASDAQ |
Apr 19, 16:00
3.29
0.00 (0.00%)
After-Hours: 20:00
MEI Pharma Cash from Investing (TTM): 58.90M for Dec. 31, 2023
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
Date | Value |
---|---|
December 31, 2023 | 58.90M |
September 30, 2023 | 44.91M |
June 30, 2023 | 53.69M |
March 31, 2023 | 54.41M |
December 31, 2022 | 59.54M |
September 30, 2022 | 5.634M |
June 30, 2022 | 6.892M |
March 31, 2022 | -3.232M |
December 31, 2021 | -3.00M |
September 30, 2021 | 35.22M |
June 30, 2021 | 24.71M |
March 31, 2021 | -70.33M |
December 31, 2020 | -76.61M |
September 30, 2020 | -106.78M |
June 30, 2020 | -106.29M |
March 31, 2020 | -11.29M |
December 31, 2019 | -10.63M |
September 30, 2019 | 24.50M |
June 30, 2019 | 24.32M |
March 31, 2019 | -45.07M |
December 31, 2018 | -49.74M |
September 30, 2018 | -44.58M |
June 30, 2018 | -44.33M |
March 31, 2018 | 15.06M |
December 31, 2017 | 4.953M |
Date | Value |
---|---|
September 30, 2017 | 4.998M |
June 30, 2017 | -10.08M |
March 31, 2017 | -10.01M |
December 31, 2016 | 0.006M |
September 30, 2016 | -4.976M |
June 30, 2016 | 9.972M |
March 31, 2016 | 14.94M |
December 31, 2015 | 14.93M |
September 30, 2015 | -15.14M |
June 30, 2015 | -10.06M |
March 31, 2015 | -15.09M |
December 31, 2014 | -35.10M |
September 30, 2014 | -25.06M |
June 30, 2014 | -35.07M |
March 31, 2014 | -35.04M |
December 31, 2013 | -20.04M |
September 30, 2013 | -0.042M |
June 30, 2013 | -0.038M |
March 31, 2013 | -0.028M |
December 31, 2012 | -0.004M |
September 30, 2012 | -0.002M |
June 30, 2012 | 0.00 |
March 31, 2012 | 0.00 |
December 31, 2011 | 0.00 |
September 30, 2011 | 0.00 |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
-106.78M
Minimum
Sep 2020
59.54M
Maximum
Dec 2022
0.2392M
Average
6.892M
Median
Jun 2022
Cash from Investing (TTM) Benchmarks
Merck & Co Inc | -14.08B |
United Therapeutics Corp | -719.60M |
Macrogenics Inc | -80.08M |
Voyager Therapeutics Inc | -141.64M |
Moderna Inc | 4.206B |